Sergey Karakashev

Sergey Karakashev supports capacity-building efforts in the field of cancer research, with a particular focus on ovarian cancer and epigenetics. As an Assistant Professor in the Cancer & Cellular Biology and Fels Cancer Institute for Personalized Medicine departments at the Lewis Katz School of Medicine at Temple University, he is dedicated to advancing our understanding of high-grade serous ovarian cancer (HGSOC). His research aims to uncover the intricate epigenetic mechanisms that drive this aggressive form of cancer. Dr. Karakashev's work is centered on the development of personalized therapeutic interventions that are tailored to the unique epigenetic landscapes of individual patients. By exploring the complex interplay between genetic and epigenetic factors, he seeks to identify novel targets for treatment and improve outcomes for those affected by ovarian cancer. His research has the potential to revolutionize the way we approach cancer therapy, moving towards more precise and effective strategies. In addition to his research endeavors, Dr. Karakashev is committed to mentoring the next generation of scientists. He actively engages with students and colleagues, fostering an environment of collaboration and innovation. His dedication to education and research excellence is reflected in his numerous publications and contributions to the scientific community. Dr. Karakashev's passion for cancer research is driven by a desire to make a meaningful impact on patient care. Through his work, he hopes to contribute to the development of therapies that not only extend lives but also enhance the quality of life for individuals battling ovarian cancer.